Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
Clinical trial NCT06477237 · UNKNOWN
Trial details
- NCT number
- NCT06477237
- Sponsor
- Huabo Biopharm Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2024-08-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.